^Thomas J. Kindt; Richard A. Goldsby; Barbara Anne Osborne; Janis Kuby (2006). Kuby Immunology (6 изд.). New York: W H Freeman and company. ISBN1429202114.
Knoops L, Renauld JC (2005). „IL-9 and its receptor: from signal transduction to tumorigenesis.”. Growth Factors. 22 (4): 207—15. PMID15621723. doi:10.1080/08977190410001720879.
WS, Modi; Pollock DD; Mock BA (1991). „Regional localization of the human glutaminase (GLS) and interleukin-9 (IL9) genes by in situ hybridization.”. Cytogenet. Cell Genet. 57 (2-3): 114—6. PMID1680606. doi:10.1159/000133126.
K, Kelleher; Bean K; Clark SC (1991). „Human interleukin-9: genomic sequence, chromosomal location, and sequences essential for its expression in human T-cell leukemia virus (HTLV)-I-transformed human T cells.”. Blood. 77 (7): 1436—41. PMID1901233.
ST, Holbrook; Ohls RK; Schibler KR (1991). „Effect of interleukin-9 on clonogenic maturation and cell-cycle status of fetal and adult hematopoietic progenitors.”. Blood. 77 (10): 2129—34. PMID1903074.
H, Merz; Houssiau FA; Orscheschek K (1991). „Interleukin-9 expression in human malignant lymphomas: unique association with Hodgkin's disease and large cell anaplastic lymphoma.”. Blood. 78 (5): 1311—7. PMID1908723.
JC, Renauld; Goethals A; Houssiau F (1990). „Human P40/IL-9. Expression in activated CD4+ T cells, genomic organization, and comparison with the mouse gene.”. J. Immunol. 144 (11): 4235—41. PMID1971295.
JC, Renauld; Goethals A; Houssiau F (1991). „Cloning and expression of a cDNA for the human homolog of mouse T cell and mast cell growth factor P40.”. Cytokine. 2 (1): 9—12. PMID2129501. doi:10.1016/1043-4666(90)90037-T.
YC, Yang; Ricciardi S; Ciarletta A (1989). „Expression cloning of cDNA encoding a novel human hematopoietic growth factor: human homologue of murine T-cell growth factor P40.”. Blood. 74 (6): 1880—4. PMID2508790.
T, Yin; Keller SR; Quelle FW (1995). „Interleukin-9 induces tyrosine phosphorylation of insulin receptor substrate-1 via JAK tyrosine kinases.”. J. Biol. Chem. 270 (35): 20497—502. PMID7544789. doi:10.1074/jbc.270.35.20497.
DS, Postma; Bleecker ER; Amelung PJ (1995). „Genetic susceptibility to asthma--bronchial hyperresponsiveness coinherited with a major gene for atopy.”. N. Engl. J. Med. 333 (14): 894—900. PMID7666875. doi:10.1056/NEJM199510053331402.
MM, Le Beau; Espinosa R; Neuman WL (1993). „Cytogenetic and molecular delineation of the smallest commonly deleted region of chromosome 5 in malignant myeloid diseases.”. Proc. Natl. Acad. Sci. U.S.A. 90 (12): 5484—8. PMID8516290. doi:10.1073/pnas.90.12.5484.
NC, Nicolaides; Holroyd KJ; Ewart SL (1998). „Interleukin 9: a candidate gene for asthma.”. Proc. Natl. Acad. Sci. U.S.A. 94 (24): 13175—80. PMID9371819. doi:10.1073/pnas.94.24.13175.
JB, Demoulin; E, Van Roost; Stevens M (1999). „Distinct roles for STAT1, STAT3, and STAT5 in differentiation gene induction and apoptosis inhibition by interleukin-9.”. J. Biol. Chem. 274 (36): 25855—61. PMID10464327. doi:10.1074/jbc.274.36.25855.
Lejeune D, Demoulin JB, Renauld JC (2001). „Interleukin 9 induces expression of three cytokine signal inhibitors: cytokine-inducible SH2-containing protein, suppressor of cytokine signalling (SOCS)-2 and SOCS-3, but only SOCS-3 overexpression suppresses interleukin 9 signalling.”. Biochem. J. 353 (Pt 1): 109—116. PMID11115404. doi:10.1042/0264-6021:3530109.
Little FF, Cruikshank WW, Center DM (2001). „Il-9 stimulates release of chemotactic factors from human bronchial epithelial cells.”. Am. J. Respir. Cell Mol. Biol. 25 (3): 347—52. PMID11588013.
C, Pilette; Ouadrhiri Y; J, Van Snick (2002). „IL-9 inhibits oxidative burst and TNF-alpha release in lipopolysaccharide-stimulated human monocytes through TGF-beta.”. J. Immunol. 168 (8): 4103—11. PMID11937570.
Спољашње везе
Interleukin-9 на US National Library of Medicine Medical Subject Headings (MeSH)